A.I.dvisor tells us that EVO and ACB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVO and ACB's prices will move in lockstep.
Ticker / NAME | Correlation To EVO | 1D Price Change % |
---|---|---|
EVO | 100% | +3.26% |
Pharmaceuticals: Generic industry (223 stocks) | 5% Poorly correlated | +2.48% |